GluK2 kainate receptor subunit-selective, potentiating RNA aptamer.

Area of Science:

• Neuroscience
• Molecular Biology
• Drug Discovery

Background:

• Kainate receptors are ionotropic glutamate receptors crucial for neurological function.
• Dysregulation of kainate receptors is implicated in various neurological diseases.
• Selective modulators of kainate receptors are sought as potential therapeutic agents.

Purpose of the Study:

• To discover potent and subunit-selective modulatory agents for kainate receptors.
• To engineer an RNA aptamer with enhanced selectivity for the GluK2 subunit.
• To explore the combination of molecular docking and functional assays for aptamer discovery.

Main Methods:

• Design and synthesis of RNA aptamers targeting kainate receptors.
• Modification of a non-selective inhibitor RNA to create a potentiator.
• Utilizing molecular docking simulations to guide aptamer design.
• Functional assays to evaluate aptamer potency and subunit selectivity.

Main Results:

• An RNA aptamer, U9, was engineered to selectively potentiate the GluK2 kainate receptor subunit.
• U9 demonstrated potentiation with an EC50 of approximately 210 nM.
• The study successfully demonstrated a template-based approach for discovering selective RNA aptamers.

Conclusions:

• The U9 aptamer represents a potent and selective potentiator of the GluK2 subunit.
• This work highlights the utility of integrating computational and experimental methods for aptamer engineering.
• The findings provide a foundation for developing novel therapeutics targeting specific kainate receptor subunits.